Abdomen (most people prefer this area): The stomach is one of the easiest places to inject semaglutide and some people find it hurts less than other areas
The trial showed people who took the pill experienced similar side effects as those on injectables, Novo Nordisk said, including gastrointestinal issues such as nausea, diarrhea and vomiting
Eli Lilly said in May that it will pile $5.3 billion into manufacturing its popular weight loss drugs, more than doubling its investment in a manufacturing facility in Lebanon, Indiana
FDA-approved uses Zepbound is FDA-approved for chronic weight management and treatment of moderate to severe obstructive sleep apnea (OSA) in patients with obesity (body mass index (BMI) of 30 kg/m or higher) and overweight (BMI of 27 or higher) with at least one weight-related condition that is caused or worsened by being overweight
In front of such a wide range of options, as well as of the unmet need for every obese patient, the task to accomplish remains finding out the optimal individually tailored therapeutic regimen to treat obesity
